Risedronate sodium hemi-pentahydrate is used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and from glucocorticoid therapy. Paget’s disease of bone, to normalize bone remodeling. It works by inhibiting bone resorption, increasing bone density. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Actonel (TN), Sodium risedronate hydrate (JP17) and KS-1105. Its PubChem CID is 11954322.
Risedronate sodium hemi-pentahydrate
| CAS No | 329003-65-8 |
|---|---|
| Molecular Formula | C14H30N2Na2O19P4 |
| Molecular Weight | 700.26 g/mol |
| Synonyms | disodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate;pentahydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Risedronate sodium hemi-pentahydrate is used for: Treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis in men and from glucocorticoid therapy.
The listed CAS number is 329003-65-8.
The listed molecular formula is C14H30N2Na2O19P4.
The listed molecular weight is 700.26 g/mol.
disodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate;pentahydrate.
The source lists Actonel (TN), Sodium risedronate hydrate (JP17) and KS-1105.